|
⚲
|
| Keyboard |
| Nazak Michael Adrian
✚
|
|
|---|---|
| CIK # | 0001799731 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001799731] | |
| 4 | [0001799731] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| AN2 Therapeutics Inc | |
| Nazak Michael Adrian | |
| Aridis Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2023-02-15 | Grant | 16,600 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2022-05-12 | Grant | 14,300 | $0.00 | |
|
Aridis Pharmaceuticals Inc ARDS
Stock Options · derivative
|
2021-02-18 | Option exercise | 20,000 | $0.00 | |
|
Aridis Pharmaceuticals Inc ARDS
Stock Options · derivative
|
2020-01-02 | Option exercise | 20,000 | $0.00 |